Intravaginal poly-(D, L-lactic-co-glycolic acid)-(polyethylene glycol) drug-delivery nanoparticles induce pro-inflammatory responses with Candida albicans infection in a mouse model

• Taslima T. Lina,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliations Microbiology Division, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas, United States of America, Office of Regulatory and Risk Management, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas, United States of America

  ⨯
• Shemedia J. Johnson,

  Roles Formal analysis, Methodology

  Affiliation Microbiology Division, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas, United States of America

  ⨯
• R. Doug Wagner

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – review & editing

  * E-mail: doug.wagner@fda.hhs.gov

  Affiliation Microbiology Division, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas, United States of America

  https://orcid.org/0000-0002-4738-5097

  ⨯